Saturday, May 13, 2017 12:07:16 AM
This is from page 7 of the annual report on 4/19/2017
They paid Dr. Phillips for the technology and then upgraded it and have provisional patents
On January 31, 2014, the Company purchased an exclusive license (the "License") on the patent pending
technology from Dr. Howard Phillips represented by US Patent application #20130190274. The Company
amended the License on January 20, 2017 such that it is now a non-exclusive distribution and licensing agreement.
Apart from the technology licensed from Dr. Howard Phillips, the Company is currently using a second generation
transdermal technology to manufacture and develop its products. This technology was exclusively
licensed from a related party. During 2016, provisional patents were been filed on this technology. The Company
received provisional patent #62433964 ‘AQUEOUS TOPICAL SOLUTIONS for this technology. The Company
believes the newer technology has additional benefits and plans to incorporate this topical delivery system into
most, if not all of its future products.
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM